ArticleCase reports in oncology

Immune Checkpoint Inhibitor-Induced Bullous Pemphigoid: Successful Treatment with Dupilumab while Maintaining Immunotherapy.

Cristina-Maria Florea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.